Role of microRNAs in obesity and obesity-related diseases

被引:5
|
作者
Giuseppe Iacomino
Alfonso Siani
机构
[1] Institute of Food Sciences,
[2] CNR,undefined
来源
Genes & Nutrition | 2017年 / 12卷
关键词
Obesity; Metabolic disease; Disease biomarkers; miRNAs; microRNA;
D O I
暂无
中图分类号
学科分类号
摘要
In recent years, the link between regulatory microRNAs (miRNAs) and diseases has been the object of intensive research. miRNAs have emerged as key mediators of metabolic processes, playing crucial roles in maintaining/altering physiological processes, including energy balance and metabolic homeostasis. Altered miRNAs expression has been reported in association with obesity, both in animal and human studies. Dysregulation of miRNAs may affect the status and functions of different tissues and organs, including the adipose tissue, pancreas, liver, and muscle, possibly contributing to metabolic abnormalities associated with obesity and obesity-related diseases. More recently, the discovery of circulating miRNAs easily detectable in plasma and other body fluids has emphasized their potential as both endocrine signaling molecules and disease indicators. In this review, the status of current research on the role of miRNAs in obesity and related metabolic abnormalities is summarized and discussed.
引用
收藏
相关论文
共 50 条
  • [21] The Role of LncRNA TUG1 in Obesity-related Diseases
    Xue, Mengzhen
    Xia, Fangqi
    Wang, Yaqi
    Zhu, Leiqi
    Li, Yuanyang
    Jia, Dengke
    Gao, Yan
    Shi, Yue
    Zhang, Changcheng
    He, Yumin
    Liu, Chaoqi
    Yuan, Ding
    Yuan, Chengfu
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2022, 22 (09) : 1305 - 1313
  • [22] The challenge of obesity-related chronic diseases
    Jeanne M. Clark
    Frederick L. Brancati
    Journal of General Internal Medicine, 2000, 15 : 828 - 829
  • [23] Role of Nuclear Receptors in Lipid Dysfunction and Obesity-Related Diseases
    Swanson, Hollie I.
    Wada, Taira
    Xie, Wen
    Renga, Barbara
    Zampella, Angela
    Distrutti, Eleonora
    Fiorucci, Stefano
    Kong, Bo
    Thomas, Ann M.
    Guo, Grace L.
    Narayanan, Ramesh
    Yepuru, Muralimohan
    Dalton, James T.
    Chiang, John Y. L.
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (01) : 1 - 11
  • [24] Promising new causal explanations for obesity and obesity-related diseases
    Power, Carrie
    Miller, Sally K.
    Alpert, Patricia T.
    BIOLOGICAL RESEARCH FOR NURSING, 2007, 8 (03) : 223 - 233
  • [25] Autotaxin-LPA Axis in Obesity and Obesity-related Diseases
    Yin Nan
    Zhang Jun-Jie
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2021, 48 (07) : 768 - 778
  • [26] New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases
    Adeeb Shehzad
    Taewook Ha
    Fazli Subhan
    Young Sup Lee
    European Journal of Nutrition, 2011, 50 : 151 - 161
  • [27] New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases
    Shehzad, Adeeb
    Ha, Taewook
    Subhan, Fazli
    Lee, Young Sup
    EUROPEAN JOURNAL OF NUTRITION, 2011, 50 (03) : 151 - 161
  • [28] The perspectives of NETosis on the progression of obesity and obesity-related diseases: mechanisms and applications
    Li, Jinyu
    Yin, Lijia
    Chen, Siyi
    Li, Zelin
    Ding, Jiatong
    Wu, Jiaqiang
    Yang, Kangping
    Xu, Jixiong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [29] Role of leptin in obesity-related hypertension
    Aizawa-Abe, M
    Ogawa, Y
    Masuzaki, H
    Ebihara, K
    Shintani, M
    Miyanaga, F
    Nakao, K
    JOURNAL OF HYPERTENSION, 2000, 18 : S120 - S120
  • [30] Adiponectin and insulin resistance in obesity-related diseases
    Ebinc, H.
    Ozkurt, Z. N.
    Ebin, F. A.
    Yilmaz, M.
    Caglayan, O.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2008, 36 (01) : 71 - 79